Nasdaq notifies InterGroup of MVLS non-compliance; cure period to May 2025

INTERGROUP CORP

Received Nasdaq Deficiency Letter on Nov 21, 2024 for MVLS below $35M from Oct 7 to Nov 20, 2024.
Non-compliance with Listing Rules 550(b)(1) and 5550(b)(3) on Nasdaq Capital Market.
Company has until May 20, 2025 to regain compliance by closing MVLS at $35M+ for 10 consecutive business days.
Failure to cure may result in Nasdaq delisting proceedings.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.